Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vivozon Pharmaceutical Co Ltd
Common Shares Outstanding
Vivozon Pharmaceutical Co Ltd
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
|
Common Shares Outstanding
₩52.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
SK Hynix Inc
KRX:000660
|
Common Shares Outstanding
₩701.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
DB HiTek Co Ltd
KRX:000990
|
Common Shares Outstanding
₩42.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
H
|
Hana Micron Inc
KOSDAQ:067310
|
Common Shares Outstanding
₩59.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
L
|
Leeno Industrial Inc
KOSDAQ:058470
|
Common Shares Outstanding
₩75.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
F
|
Fadu Inc
KOSDAQ:440110
|
Common Shares Outstanding
₩49.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vivozon Pharmaceutical Co Ltd
Glance View
Vivozon Pharmaceutical Co., Ltd. engages in the manufacture and sale of compound semiconductors. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2005-11-18. The firm operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
See Also
What is Vivozon Pharmaceutical Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
52.1m
KRW
Based on the financial report for Sep 30, 2025, Vivozon Pharmaceutical Co Ltd's Common Shares Outstanding amounts to 52.1m KRW.
What is Vivozon Pharmaceutical Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
21%
Over the last year, the Common Shares Outstanding growth was 4%. The average annual Common Shares Outstanding growth rates for Vivozon Pharmaceutical Co Ltd have been 2% over the past three years , 13% over the past five years , and 21% over the past ten years .
